Subgroup | Studies (n) | WMD (95%CI) | Test for overall effect | Study heterogeneity | P for meta-regression | ||
---|---|---|---|---|---|---|---|
 |  |  |  | χ2 | P | I2 |  |
Overnight fast | Â | Â | Â | Â | Â | Â | 0.269 |
Yes | 28 | 2.41 (1.41, 3.41) | Z =4.71, P <0.001 | 481.24 | <0.001 | 94.4% | Â |
No | 7 | 1.20 (0.25, 2.16) | Z =2.46, P =0.014 | 23.70 | 0.001 | 74.7% | Â |
Diagnosis | Â | Â | Â | Â | Â | Â | 0.343 |
RVOa | 18 | 2.56 (1.39, 3.72) | Z =4.31, P <0.001 | 222.86 | <0.001 | 92.4% | Â |
CRVO | 17 | 1.67 (0.39, 3.00) | Z =2.55, P =0.011 | 314.88 | <0.001 | 94.9% | Â |
Source of cases | Â | Â | Â | Â | Â | Â | 0.696 |
Hospital records | 9 | 1.60 (0.47, 2.74) | Z =2.76, P =0.006 | 52.86 | <0.001 | 84.9% | Â |
Consecutive patients | 26 | 2.24 (1.25, 3.23) | Z =4.44, P <0.001 | 401.13 | <0.001 | 93.8% | Â |
Adjusting factors | Â | Â | Â | Â | Â | Â | 0.245 |
NA | 1 | 4.30 (3.80, 4.80) | Z =17.00, P <0.001 | - | - | - | Â |
Age | 10 | 1.33 (0.47, 2.18) | Z =3.05, P =0.002 | 32.23 | <0.001 | 72.1% | Â |
Age, sex | 24 | 2.34 (1.19, 3.50) | Z =3.98, P <0.001 | 409.41 | <0.001 | 94.4% | Â |